Government interrogates prices to stymie £200m-plus drugs overspend
Government has begun intensively monitoring new information on the generic drug market to try to stymie additional costs which are running into hundreds of millions of pounds, HSJ has been told.
You need to be an HSJ subscriber to read more
Subscribe to read the full article
With an HSJ subscription you’ll get access to:
- Expert Briefing newsletters, covering nine topics and regions
- Weekly Catch Up – a summary of the week’s most important stories
- Unlimited access to hsj.co.uk
- The HSJ app
Enquire about multi-user access